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Abstract
In mice, social behaviors such asmating and aggression are mediated by pheromones and
related chemosignals. The vomeronasal organ (VNO) detects olfactory information from
other individuals by sensory neurons tuned to respond to specific chemical cues. Receptors
expressed by vomeronasal neurons are implicated in selective detection of these cues.
Nearly 400 receptor genes have been identified in the mouse VNO, but the tuning properties
of individual receptors remain poorly understood, in part due to the lack of a robust heterolo-
gous expression system. Here we develop a herpes virus-based amplicon delivery system to
overexpress three types of vomeronasal receptor genes and to characterize cell responses to
their proposed ligands. Through Ca2+ imaging in native VNO cells we show that virus-induced
overexpression of V1rj2, V2r1b or Fpr3 caused a pronounced increase of responsivity to sul-
fated steroids, MHC-binding peptide or the synthetic hexapeptideW-peptide, respectively.
Other related ligands were not recognized by infected individual neurons, indicating a high
degree of selectivity by the overexpressed receptor. Removal of G-protein signaling elimi-
nates Ca2+ responses, indicating that the endogenous secondmessenger system is essential
for observing receptor activation. Our results provide a novel expression system for vomero-
nasal receptors that should be useful for understanding the molecular logic of VNO ligand
detection. Functional expression of vomeronasal receptors and their deorphanization pro-
vides an essential requirement for deciphering the neural mechanisms controlling behavior.
Introduction
In mice and other terrestrial vertebrates, social behavior and reproductive physiology are medi-
ated by chemosignals that are recognized by the olfactory systems [1,2]. The accessory (or vom-
eronasal) olfactory system seems to specialize in social interactions such as those conveyed by
pheromones, kairomones, and other socially relevant chemosignals. These molecular cues are
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detected in the vomeronasal organ (VNO) by sensory neurons that express three major families
of G protein-coupled receptors (GPCRs), vomeronasal receptors (VRs) type 1 and 2 (V1Rs and
V2Rs), and formyl peptide receptors (Fprs) [3–6]. These receptors have been implicated in rec-
ognizing a highly diverse collection of ligands and initiating transduction in vomeronasal sen-
sory neurons (VSNs). However, only few receptors from a repertoire of nearly 400 functional
genes have been paired with molecularly defined ligands. In part, this is a direct consequence
of the lack of a suitable expression system to enable in vitro receptor analysis of ligand specific-
ity. Gene transfer and functional expression of cloned vomeronasal receptors is a fundamental
requirement for providing a causal link between receptor activation and ligand recognition and
understanding the chemical receptive properties that, in turn, provide the foundation for neu-
ral coding of social odorants.
Identification of a few vomeronasal receptor-ligand pairings has been possible by using
gene-targeted mice that express fluorescent markers in specific sensory neurons and, in some
cases, through genetic deletion of receptors. Known receptor-ligand pairs include V1rj2 and
V1rj3 paired with sulfated steroids [7], V1rb2 paired with 2-heptanone [8], V2rp5 paired with
ESP1 peptide [9], and V2r1b and V2rf2 paired with 9-mer peptides [10,11]. Despite recent
advances in genome editing, generation of knockin and knockout mice is still costly and time
consuming, and in consequence impractical to cover the enormous vomeronasal receptor rep-
ertoire. As a rare exception, two V2Rs (V2rp1 and V2rp2, which also detect ESP peptides) and
one Fpr (Fpr3, previously known as Fpr-rs1, detecting bacterial signal peptides) have been func-
tionally expressed in heterologous cells [12–15]. To our knowledge, however, this approach
was not effectively used with other VRs and Fprs, thus far. A rapid and uncomplicated expres-
sion system that covers any vomeronasal receptor type would provide an invaluable tool for
understanding the logic of information processing in the VNO.
A functional expression system for vomeronasal receptors requires first that the receptors are
properly localized to the surface of the cells, and second that they couple efficiently with a sec-
ond messenger system that generate a measurable response to ligand stimulation. We reasoned
that native VSNs themselves would be the most competent cells for expressing, localizing, and
coupling vomeronasal receptors. Further support for this assumptions comes from the existence
of only two major signaling cascades in the VNO: one that involves the G-protein Gαi2 used by
V1R-expressing VSNs that are localized in the apical VNO layer, and a second one that involves
Gαo in basal, V2R-positive VSNs [16–19]. Fpr signaling also seems to follow similar segregation
rules as determined by G-protein expression: Fpr-rs3, 4, 6 and 7 co-localize with Gαi2 whereas
Fpr3 co-localizes with Gαo [20]. Here, we rely on the large number of native VSNs expressing
either Gαi2 or Gαo to develop an expression system, driving the expression of selected members
from each of the V1R, V2R or Fpr families by delivering them through a herpes virus amplicon
vector and infecting VSNs in vitro. Infected individual cells are identified by bicistronic expres-
sion of marker green fluorescent protein (GFP), allowing responses to specific ligands to be
tested in single cells. Ca2+ imaging recordings show that ectopic expression of a single V1R, V2R
or Fpr gene causes a significant increase in the number of responses to cognate ligands in VSNs
overexpressing one of these receptors. Our results provide a simple and effective system for
functional expression of three types of vomeronasal receptors that should be useful in the deor-
phanization effort of these important receptor families.
Methods
Mice
Animal care and experimental procedures were performed in accordance with the German Ani-
mal Welfare Act, European Communities Council Directive 2010/63/EU, and the institutional
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ethical and animal welfare guidelines of the University of Saarland (approval number of the
Institutional Animal Care and Use Committee: H-2.2.4.1.1). Male C57Bl/6, OMP-GFP mice
(B6.OMPtm3Mom/MomJ; originally JR# 006667) [21] and Gnao1/OMP-Cre conditional Gαo
knockout [22–24] mice were used. Mice were 6–15 weeks old and were kept under standard
light/dark cycle (12:12) with food and water ad libitum. Mice were euthanized by CO2 asphyxia-
tion followed by cervical dislocation as directed by the guidelines of the University of Saarland.
VSN primary culture
To obtain freshly dissociated VSNs, the mouse VNO epithelium was detached from the carti-
lage and minced in PBS at 4°C. The tissue was incubated (20 min at 37°C) in PBS supple-
mented with papain (0.22 U/ml) and DNase I (10 U/ml; Fermentas), gently washed and
centrifuged (100 × g, 5 min) in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) sup-
plemented with 10% fetal bovine serum (FBS; Gibco). Dissociated cells were plated for 1 h on
coverslips previously coated with concanavalin-A type V (0.5 mg/ml, overnight at 4°C; Sigma).
Cells were either used immediately for imaging (Fig 1), or infected with virus and incubated at
37°C in FBS-supplemented DMEMmedium for 20–24h before imaging.
Calcium imaging
Imaging was performed as described [22,24,25]. Briefly, cells were loaded with the Ca2+ indica-
tor fura-2/AM (5 μM; Invitrogen). Coverslips containing fura-2-loaded VSNs were placed in a
laminar-flow chamber (Warner Instruments) and constantly perfused with extracellular
Hank’s balanced salt solution (HBSS) supplemented with 10mMHepes (2-[4-(2-hydroxyethyl)
piperazin-1-yl]ethanesulfonic acid). Calcium imaging on HSV-infected cells was performed
20–24 h post infection. Ratiometric (F340/F380) fura-2 Ca2+ imaging was performed using an
Olympus IX71 microscope equipped with a Hamamatsu camera. Image pairs were acquired at
0.25 Hz and analyzed using ImageJ (NIH). Chemostimuli were bath applied for 30 s. Image
processing and data analysis, including region of interest (ROI) detection and signal analyses,
were performed using ImageJ (NIH) and Origin8.6 (OriginLab). ROIs were selected manually
and peak signals calculated from the temporal profiles of image ratio values. A response was
defined as a stimulus-dependent deviation in fluorescence ratio that exceeds 1.5 the standard
deviation of the mean of the baseline.
Chemostimulation
Chemostimuli for Ca2+ imaging were prepared fresh daily and diluted in Hepes-buffered
HBSS, giving the following final concentrations: SYFPEITHI, 5×10−11 M; urine high molecular
fraction (HMW) 1:300 dilution; sulfated estrogen mix (E mix): E1050 (1, 3, 5(10)-estratrien-3,
17β-diol disulphate), E1100 (1, 3, 5(10)-estratrien-3, 17β-diol 3-sulphate), E0893 (1, 3, 5(10)-
estratrien-3, 17α-diol 3-sulphate) and E0588 (17β-dihydroequilin D 3-sodium sulphate), each
at 100 μM (Steraloid); E2734 (1, 3, 5(10)-estratrien-3, 16α, 17β-triol 17-sulphate), 100 μM;W-
peptide (WKYMVm), 1μM; mitochondria-derived ND1-peptide (f-MFFINTLTL), 10−7 M;
KCl, 100 mM; ATP (adenosine triphosphate), 60 μM. Sulfated estrogens were prepared in
DMSO (dimethyl sulfoxide) and further diluted into Hepes-HBSS. A solution containing the
same amount of DMSO (labeled as DMSO in Figs 1–3) was used as a control stimulation for
E1050 or the sulfated estrogen mix. To obtain HMW fraction, fresh urine was collected from
adult C57Bl/6 males (8–12 week old, sexually naïve) and size-fractionated by centrifugation
(14,000 × g for 30 min) using Microcon 10-kDa molecular mass cutoff ultrafiltration columns
(Millipore). The centrifugation retentate was washed with one volume of PBS three times and
resuspended in PBS to the initial volume of urine. The MHC-peptide SYFPEITHI was initially
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dissolved in a solution containing: 120 mMNaCl, 25 mM NaHCO3, 5 mM KCl, 5 mM N,N-bis
[2-hydroxyethyl]-2-aminoethanesulfonic acid (BES), 1 mMMgSO4, 1 mM CaCl2, 10 mM glu-
cose] to give 100 μM stock solutions. Further dilutions were made in Hepes-buffered HBSS.
Single-cell RT-PCR
Single-cell cDNAs were reverse transcribed and amplified by a previously described procedure
[26]. VSNs exhibiting a specific response profile identified in Ca2+ imaging were picked using a
glass capillary (~10 μm tip size) in 1 μl of Hepes-HBSS. Single cells were then transferred to a
PCR tube containing 1μl of diethylpyrocarbonate (DEPC) treated water. Samples were imme-
diately frozen on dry ice and kept at −80°C until use. Cells were lysed in 5μl of a NP-40 based
lysis buffer by incubation at 65°C for 1min. Reverse transcription (RT) was performed with
anchor-T primer (TATAGAATTCGCGGCCGCTCGCGA[T]24) and Superscript III (Invitrogen)
at 37°C for 90 min and at 50°C for 15 min. Reactions were stopped by heating at 70°C for 10
min. Next, a tailing reaction was performed using TdT, dATP and RNAseH (Roche) at 37°C
for 20 min, followed by incubation at 65°C for 10 min. For analysis of gene expression, RT-
tailed products were first amplified by PCR reaction with EX-Taq HS DNA polymerase
(Takara) and anchor-T primer by incubating at 95°C for 2 min, 37°C for 5 min, 72°C for 20
min, then 30 cycles of 95°C for 30 s, 67°C for 1 min, 72°C for 6 min plus 6 s extension for each
Fig 1. Single-cell RT-PCR following Ca2+ imaging and cell isolation. (A) Representative intracellular Ca2+
increase (F340/380 ratio, arbitrary units) of a VSN (cell “A”) loaded with fura-2 in response to the sulfated
steroid E1050 (chemical structure shown on the side), but not to urine high molecular weight fraction (HMW).
(B) Ratiometric (340/380) imaging of the cell shown in A during stimulation with control buffer (DMSO) and
E1050. Responsive cells are later picked using a glass capillary micropipette. Arrowhead points to the cell
before and after (inside of the micropipette) picking. Scale bar, 10 μm. (C) Ethidium-bromide stained agarose
gels of RT-PCR products generated from 5 cells (A to E) showing Ca2+ responses to E1050, a single cell
lacking responses (n/r), and two water controls (w1 and w2). cDNA collected from pooled whole VNOs was
used as positive control (VNO). PCR amplification of cDNA collected from single cells was performed using
gene specific primers forOmp,Gnao1 (Gαo),Gnai2 (Gαi2) and degenerate primers for three members of the
V1rj family.
doi:10.1371/journal.pone.0156092.g001
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cycle, then 72°C for 10 min. The second round of PCR was with the following primers: V1rj:
CATCACTCCCAGTAAYTCTAAGTGGGC and GCTGGGMTCTCTTGTRRTGYCTGTAGAG;
Gnai2: GAGCATGAAGCTGTTTGACAGC and CTCCTTGGTGTCTTTGCGC; Omp: GCACAGT
TAGCAGGTTCAGCT and GGTTTGCAGTCCTGGCAGC; Gnao: CTCCACGAGGACGAAACCAC
and GCCCCGGAGATTGTTGGCA. V1rj primers are designed to capture V1rj2 (Vmn1r89),
V1rj3 (Vmn1r85), and Vmn1r86 genes. Total VNO mRNA was obtained from pooled C57Bl/6
adult mice (both genders) VNO tissue using PureLink RNAMini Kit (Ambion) according to
the manufacturer’s instructions. Traces of genomic DNA were digested by incubation with
30U of DNase I (Fermentas).
Receptor cloning
V1rj2 (Vmn1r89), V2r1b (Vmn2r24) and Fpr3 (previously known as Fpr-rs1) receptor cDNA
cloning was performed by RT-PCR using C57Bl/6 mice pooled VNOmRNA and gene-specific
primers: V1rj2: ATGTTTTCAAGTGACACATTCTTCCAGA and TCAGCCATGCAGTGAACTTT
GATG; V2r1b: ATGAAATTACTCACTGCTTTCTCTCC and TCATTTAAAGAACTTCTTTCTT
GAATG; Fpr3: ATGGAAACCAACTACTCTATCCCTTTGAAT and TATTGCCTTTATTTCAAT
GTCTTCAGGAAGT. PCR products were cloned first into TOPO or pGEM-T vectors and sub-
cloned into pHSV-IRES-GFP vector followed by sequence analysis. The bicistronic pHSV-
IRES-GFP amplicon was created by ligating the IRES-EGFP1 cassette previously excised
with NotI/XbaI from the parental pIRES-GFP plasmid into the pHSVpUC amplicon linearized
with the same restriction enzymes. pHSV-IRES-mCherry was generated by replacing EGFP1
Fig 2. Herpes simplex virus type 1 (HSV-1) expression system in HEK cells and VSNs. (A) HEK cells transfected with pHSV-V1rj2-
IRES-GFP expression vector do not show responses to a mix of sulfated steroids (E mix: E1100, E0893, E0588, and E1050, each 100 μM),
HMW nor E2734 in Ca2+ imaging. (B) Infection of HEK cells (top panels) and freshly prepared VSNs (bottom panels) with HSV-GFP
amplicon virus monitored at three different time points (6 h, 24 h and 48 h). Scale bars, 50 μm (C) Left and center, measures of fluorescence
intensity (in arbitrary units, a.u.) on infected single HEK cells and VSNs. Right, normalized abundance of infected VSNs (GFP+) at each
time point. (D) Single VSNs infected with HSV-GFP virus for 20 h and loaded with fura-2. Bright field (BF), GFP and F340/380 ratio images
of an infected cell are shown. Average rate of infection was 23% (N = 16 402 cells in 69 infections). Infection rate for specific batches of
HSV: GFP, 19% (N = 10 171); V1rj2, 15% (N = 3109); V2r1b, 27% (N = 2675); Fpr3, 39% (N = 447). (E) VSNs prepared from OMP-GFP
mice infected with a HSV-mCherry virus. Of all mCherry-positive cells 76% were also positive for GFP. N = 978 mCherry+ cells in 14
infections. Scale bars, 10 μm.
doi:10.1371/journal.pone.0156092.g002
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sequence in the pHSV-IRES-GFP by mCherry cloned from pcDNA3.1/hChR2(H134R)-
mCherry, a gift from Karl Deisseroth (Addgene plasmid # 20938).
Cell lines and viruses
HEK293T (ATCC # CRL-11268) and 2–2 cells [27] were cultured in DMEMwith 4.5 g/L D-glu-
cose, supplemented with 10% FBS, 100 μg/ml penicillin and 10 μg/ml streptomycin. HEK cells
were transfected with the mammalian expression vector pHSV-IRES-GFP containing V1rj2
cDNA using lipofectamine LTX (Thermo Fisher Scientific) according to the manufacturer’s
instructions. Herpes simplex virus type-1 (HSV-1) viral particles were prepared as described [28–
30]. Briefly, pHSV-IRES-GFP and pHSV-IRES-mCherry empty vectors or containing receptor
cDNAs were packaged into replication-deficient HSV-1 particles as follows: 2–2 cells were seeded
on 60 mm dishes and transfected with the recombinant amplicon vectors using lipofectamine
LTX (Thermo Fisher Scientific) for 24h. Then, medium was replaced and cells were infected with
5dl1.2 helper virus particles containing a partial deletion in the IE2 (ICP27) gene of HSV-1. On
the following day, virus was harvested and subsequently amplified three times on fresh 2–2 cells.
VSNs and HEK cells were infected with 1–25 μl of HSV-1 (2 x 105–8 x 105 viral particles ml-1).
Statistics
Independent Student’s t-test was used for measuring the significance of difference between two
independent distributions. Mann-Whitney test was used for comparative analysis of cell-to-
Fig 3. Functional overexpression of V1rj2 in HSV-infected VSNs. (A) Diagram of the HSV-1 expression cassettes. In control amplicons
GFP is expressed under the HSV-1 IE4/5 promoter, whereas in V1rj2 amplicons V1rj2 cDNA is inserted in the multi cloning site (MCS)
upstream of IRES and GFP. (B) Bright field (BF), GFP and pseudocolor fura-2 images of a representative VSN infected with HSV-V1rj2-
IRES-GFP and activated by the mix of four sulfated estrogens (E mix). Time course of intracellular calcium is shown on the right.
Stimulations were 30 s long. Scale bar, 10 μm. (C) Color-coded heat map of normalized Δratio responses (Δrationorm) from 26 GFP+ VSNs
infected with V1rj2-IRES-GFP which showed responses to the estrogen mix (E mix). These cells lacked responses to other stimuli except
for high K+. (D) Comparison of response amplitudes expressed as normalized Δratio responses to E mix and high K of 26 individual cells
shown in C. Each neuron is shown as a separate circle. Red line represents linear fit (slope = 0.55). Responses to E mix and high K+ are not
significantly different (p = 0.92, Mann-Whitney test). (E) Summary of GFP+ cell activation for every stimulus on VSNs infected either with
V1rj2-GFP (green) or with GFP control amplicons (grey). Values are expressed as percentage (%) of activated cells from the total of GFP
+ cells. VSNs expressing V1rj2-GFP show increased cell responsivity to E mix (p < 0.005) but not to E2734, HMW, DMSO or high K+
(p = 0.1–0.4, Student’s t test). Responses to DMSO, E2734 or HMW did not overlap with responses to E-mix. N = 436 V1rj2-GFP cells and
563 control-GFP cells, in 8 and 16 experiments, respectively.
doi:10.1371/journal.pone.0156092.g003
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cell response variability. Multiple groups were compared using either one-way or two-way
analysis of variance (ANOVA) with Tukey’s test as a post hoc comparison. Analysis was per-
formed using Origin8.6 (OriginLab) software. Unless otherwise stated, results are presented as
means ± SEM.
Results
Receptor identification by Ca2+ imaging and single-cell RT-PCR
Chemosignals present in urine and other secretions are detected by VSNs using a signal cas-
cade that ultimately activates the ion channel Trpc2, causing robust intracellular Ca2+ tran-
sients [3]. We used Ca2+ imaging to identify the VRs responsible for detecting specific
chemosignals. We first targeted VSNs that showed robust Ca2+ responses to 1, 3, 5(10)-estra-
trien-3, 17β-diol disulfate (E1050) (Fig 1A and 1B), a urinary sulfated steroid previously shown
to activate VSNs [7,31]. We used a dissociated VSN preparation [22,24,25] to have access to
activated single neurons and capture the whole cell using a micro-capillary pipette (Fig 1B).
Single cells were then lysed and used as substrate for reverse transcription (RT) and cDNA
amplification, followed by PCR using primers for specific genes. Pooled VNOmRNA as well as
randomly picked single cells were used as controls. We isolated five cells responding to E1050
(cells A to E), four of which yielded a PCR product that amplified Omp (Fig 1C), encoding an
abundant cytosolic protein expressed in all mature VSNs [32]. In all cells, we also identified
expression of Gnai2, which codes for G-protein subunit Gαi2 (Fig 1C), typically expressed
together with V1R receptors in the apical layer. VSNs responding to E1050 have been previ-
ously shown to express V1Rs of the V1rj subfamily [7,31]. Thus, we used a subset of degenerate
primers designed to capture genes of this family: V1rj2 (Vmn1r89), V1rj3 (Vmn1r85), and
Vmn1r86. We identified V1rj transcripts (either V1rj2 or V1rj3) in four of the E1050-activated
cells, but not in randomly picked cells (n/r) which were not activated by E1050 (Fig 1C). Cells
were further screened for Gnao1 encoding Gαo—which is not present in V1R-expressing VSNs
—and found no detectable expression. Thus, using a combination of Ca2+ imaging and single
cell RT-PCR we were able to identify specific vomeronasal receptors expressed in a given cell.
HSV-1 expression system in intact VSNs
Identifying cognate ligands for olfactory or vomeronasal receptors in vitro has been a major
challenge [33], mostly because of the lack of a robust heterologous expression system. Among
the different vomeronasal receptors, only two V2Rs (V2rp1 and V2rp2) and one Fpr (Fpr3,
also known as Fpr-rs1) have been functionally expressed in HEK cells [12–14]. To determine
whether heterologous expression of V1Rs is feasible, we cloned V1rj2 into a mammalian
expression vector and transfected HEK cells. Further Ca2+ imaging analysis revealed that the
transfected cells—labeled with a GFP reporter—failed to show any response to a mix of sulfated
steroids (E1050, E1100, E0893, E0588, and E1050, each at 100 μM) (Fig 2A), indicating that
functional V1R expression was not effective in these cells. To circumvent this problem, we
aimed at performing ectopic expression of vomeronasal receptors in their native cellular envi-
ronment, i.e. in intact VSNs. This method has proven effective in the past by using transgenic
mice [7]. However, production of genetically altered mice is laborious and time consuming.
We reasoned that the use of a viral vector system in vitro could significantly simplify VR over-
expression in native VSNs.
To test this possibility, we attempted to maintain acutely dissociated VSNs in vitro for a
period of time sufficient to enable receptor expression, transport and localization to the plasma
membrane. We were able to keep primary VSNs in culture for 24–48 h with almost intact cell
viability using standard cell culture conditions (see Methods). Longer incubation periods
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resulted in increased cell death. Therefore, an efficient viral vector should enable fast and
robust expression under these conditions. We then examined expression at different time
points in HEK cells infected with a herpes simplex virus type 1 (HSV-1) amplicon vector.
Amplicons are defective, helper-dependent, highly versatile gene transfer vectors in which, in
contrast to other widely used viral vectors, the amplicon genome does not carry protein-encod-
ing viral sequences. Consequently, they are safe for the host and non-toxic for the infected
cells, yet with the ability to transduce cells at exceedingly high efficiencies. Furthermore, the
complete absence of virus genes provides space to accommodate very large foreign DNA
sequences, including complete genes [34]. HSV-1 is also specifically effective for infection of
VSNs because, under natural conditions, it targets the mouse VNO as a route for neuroinva-
sion of the rodent central nervous system [35]. Thus, HSV-1 derived amplicons are adequate
candidate vectors for fast and robust ectopic receptor expression in VSNs.
In HEK cells infected with a HSV-1 carrying GFP, we observed GFP fluorescence after 6 h
(Fig 2B), with a peak in fluorescence intensity after 48 h (Fig 2C). Next, we infected acutely dis-
sociated VSNs with the HSV-GFP virus and analyzed GFP fluorescence after 6, 24 and 48 h. In
VSNs, we also observed GFP expression after 6 h following infection with little or no cytotoxic
effects (Fig 2B). The relative number of cells expressing GFP increased sharply at 24 h (from
19% to 72%) and then stabilized between 24 and 48 h (Fig 2C). Maximum GFP fluorescence
intensity values were observed after 24 h and decreased at 48 h (Fig 2C), perhaps as a result of
reduced cell fitness. Therefore, in subsequent VSN experiments we used a 20–24 h interval for
optimal infection efficiency.
We evaluated the integrity of the plasma membrane by loading the cells with the Ca2+ indi-
cator fura-2 and observed robust dye uptake after 30 min of incubation (Fig 2D). On average,
we observed an infection rate of 23% of all dissociated VNO cells in culture, measured as the
number of cells positive for GFP (Fig 2D). VNO dissociation yields a mixed culture that
includes VSNs but also glial supporting cells and immature VSNs. To determine whether
VSNs were indeed infected, we used dissociated VNOs taken from OMP-GFP mice [21],
which express GFP in all mature VSNs. GFP was detectable in ~ 80% of the cells in culture,
thus unambiguously categorizing them as VSNs. Cells were then infected by HSV-1 carrying
an mCherry expression cassette (Fig 2E). Among mCherry-positive cells, 76% were also posi-
tive for GFP (Fig 2E). Hence, HSV-1 was capable of infecting both VSNs and non-VSN cells
with no evident bias for either cell type.
Functional validation of V1R viral overexpression
Next, we asked whether V1Rs overexpressed in virus-infected VSNs are functionally respon-
sive. To address this question, we cloned V1rj2 into an expression cassette of the HSV-1 ampli-
con (Fig 3A). To enable identification of infected cells, we included GFP in the expression
cassette, inserting an internal ribosomal entry site (IRES) to produce a bicistronic transcript
that results in the expression of V1R receptor and GFP as separate proteins in the same cells
(Fig 3A). Ca2+ imaging assays on cells infected with the V1rj2-IRES-GFP virus revealed a
7-fold increase in the number of responsive cells (p< 0.005) to a mix of sulfated steroids
(E1100, E0893, E0588, and E1050, each at 100 μM) as compared to responsive cells infected
with the vector expressing GFP but no V1rj2 (Fig 3B and 3E). Importantly, cells expressing
V1rj2 did not show significant Ca2+ responses to the related sulfated steroid E2734, major uri-
nary proteins contained in the high molecular weight fraction of urine (HMW), or control
buffer containing DMSO (p = 0.1–0.4) (Fig 3B, 3C and 3E). E2734 has been reported to show
no activation of V1rj2-positive cells [31], and HMWwas shown to activate V2R-positive VSNs
[22]. Thus, the response profile of VSNs infected with V1rj2-encoding virus, at least within the
HSV-1 Amplicon-Mediated Expression of Vomeronasal Receptors
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scope of the ligands screened here, was relatively specific. We used a high (100 mM) K+ solu-
tion as positive control to estimate the number of infected VSNs and their viability. Receptor-
GFP and GFP-only infected cells showed similar responses to high K+ solution (p = 0.12) indi-
cating that ectopic expression of these receptors did not affect cell excitability and survival (Fig
3E). Both high K+ and E mix evoked similar calcium transient amplitudes in individual V1rj2-
virus infected VSNs (Fig 3C and 3D), indicating that cell-to-cell response variability to E mix
was comparable to that observed for high K+.
V2Rs and Fprs functionally expressed in infected VSNs
Our results described thus far indicate that ectopic overexpression of a given V1R in VSNs via
HSV-1 mediated gene transfer results in a greatly increased number of VSNs that respond to
specific ligands for this receptor (Fig 3). On the basis of these results, we reasoned that overex-
pression of other types of vomeronasal receptors including V2Rs and Fprs should also lead to
increased responsiveness to specific ligands recognized by these receptors. To determine
whether this is the case, we cloned the receptor V2r1b (Vmn2r24) into the HSV-1 amplicon
and monitored Ca2+ responses to the class I MHC binding peptide SYFPEITHI. Previous stud-
ies in VNO tissue slices from V2r1b-IRES-tauGFP gene-targeted mice revealed that more than
half of VSNs expressing this receptor are normally activated by SYFPEITHI [10,11]. Remark-
ably, in our V2r1b-GFP virus expression system, we observed a clear 6-fold increase in the
number of cells responding to SYFPEITHI (10−11 M) stimulation versus receptor-free GFP
controls (p< 0.005) (Fig 4A and 4B). By contrast, other related ligands such as the mitochon-
dria-derived formylated peptide f-MFFINTLTL (ND1) and ligands present in the HMW frac-
tion of urine did not produce enhanced responsiveness (p = 0.37–0.65) (Fig 4B). These results
Fig 4. Viral transduction of V2r1b and Fpr3 receptors in VSNs. (A) Bright field (BF), GFP and pseudocolor fura-2 images of a VSN
infected with HSV-V2r1b-IRES-GFP (arrowhead) and activated by the MHC binding peptide SYFPEITHI (SYF). The neighboring non-
infected GFP-negative cell (arrow) does not show any calcium increase during peptide stimulation. (B) Summary of cell responses to
different stimuli. A 6-fold increase of responsivity to SYF is observed in V2r1b-GFP cells (p < 0.005, Student t test), but not to HMW fraction,
the mitochondria-derived peptide ND1, or high K+. (C) Enhanced responsivity to SYF is not observed in Gαo-deficient mice (cGαo-/-) VSNs
infected with HSV-V2r1b-IRES-GFP. (D) A single HSV-Fpr3-IRES-GFP infected VSN activated by the synthetic hexapeptide W-peptide (w-
pep) is shown. (E) Fpr3-GFP cells show a significantly enhanced number of responses to W-peptide versus GFP control cells (p < 0.001,
Student t test), but not to HMW, ND1 or high K+. N = 469 V2r1b-GFP, 163 Fpr3-GFP and 1224 control-GFP cells, in 12, 8 and 27
experiments, respectively. Scale bars, 10 μm.
doi:10.1371/journal.pone.0156092.g004
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strongly argue that our virus-based expression approach can not only be used for V1Rs but also
for V2Rs.
Both ND1 and W-peptide are known to function as Fpr agonists [13]. Fprs are expressed in
the VNO by a small subset of VSNs which do not seem to overlap with V1R- or V2R-expressing
VSNs [20]. To assess whether virus-mediated overexpression could serve to functionally
express Fprs, we infected VSNs with a HSV-1 amplicon encoding Fpr3. This receptor is specifi-
cally activated by W-peptide but not by ND1 [13]. Using Ca2+ imaging we found that W-pep-
tide activated a greatly increased number of Fpr3-GFP infected cells, by ~20 fold (p< 0.001)
compared to GFP controls (Fig 4D and 4E), whereas ND1 and HMW fraction failed to induce
higher levels of activity (p = 0.83–0.63) (Fig 4E). Hence, HSV-1-mediated gene expression is
also applicable to Fpr3.
Previous studies have shown that electrical and Ca2+ responses in the VNO evoked by SYF-
PEITHI and some formylated peptides require the participation of the G-protein subunit Gαo
[22]. To gain insight into the signaling properties of the overexpressed V2r1b receptor and to
obtain additional controls about the specificity of our expression system, we used VSNs
obtained from the Gnao1/OMP-Cre conditional Gαo knockout mouse line [22–24]. When
such VSNs were infected with V2r1b-GFP virus, Ca2+responses to SYFPEITHI were drastically
reduced (2 out of 193 cells; ~1%) (Fig 4C), now reaching similar values (p = 0.96) as those
evoked by HMW and ND1 (2 and 3 cells). This result indicates that the presence of Gαo is
required for the generation of enhanced responsiveness to SYFPEITHI in VSNs after virus-
mediated V2r1b expression. Importantly, Gαo-deficient VSNs showed normal Ca2+ transients
to high K+ solution, indicating intact viability and excitability (Fig 4C).
Discussion
We have developed a virus-based gene delivery procedure to construct an expression system
for the investigation of receptor-ligand interactions in the VNO. By choosing a selected mem-
ber from each of the three major vomeronasal receptor families–V1rj2, V2r1b and Fpr3 –we
demonstrate here that virus-induced overexpression in native VNO cells is a useful approach
to characterize and identify receptor-ligand pairs underlying molecular sensing in the VNO. In
each case, receptor overexpression resulted in a markedly increased number of infected cells
responding to specific ligands. These ligands have been linked to these receptors previously,
either through heterologous expression [13,14] or through the use of genetically modified
mouse lines [7,10,11]. Together with the direct expression system developed here, these results
provide a firm foundation for understanding the detection capabilities of specific vomeronasal
receptors.
Neither viral infection nor GFP alone were sufficient to elicit this gain in responsivity and
even closely related ligands were not recognized by the overexpressed receptor, indicating a
high specificity of our system. Because the infected cells expressed GFP, it was possible to iden-
tify individual positive neurons, allowing Ca2+ responses to be tested in single cells (Figs 3 and
4). The ligand response in virally-transduced cells followed the pattern of transient intracellular
Ca2+ increases shown in untreated cells (Fig 1A and [7,10,22,25,36,37]), indicating that the
endogenous second messenger system expressed by these neurons was most likely responsible
for generating the response in the infected cells. This view is further strengthened by the obser-
vation that infection of VSNs lacking Gαo—a key transduction molecule in basal VSNs [22]–
with viruses encoding the V2r1b receptor failed to show an increase in the responses to SYF-
PEITHI peptide (Fig 4C).
We observed a 6- to 20-fold gain in responsivity to specific ligands after infection, but the
overall number of activated cells was relatively low (about 3–5%), even though as many as 76%
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of infected cells were neurons (Fig 2E). The reasons for this are not known, but the most parsi-
monious explanation would be limited access to the correct endogenous second messenger and
trafficking systems for membrane expression. Only half of the neurons express a given G-pro-
tein, either Gαi2 or Gαo, and correct localization to the plasma membrane may require extra
components specific for particular receptors or receptor families. This could be the case for at
least certain V2Rs that seem to require calreticulin4 and/or other factors to display fully func-
tional responsive features [11,12]. It is also conceivable that some vomeronasal receptors may
form heterodimers or heteromultimers [10,38]. Thus, the possible interaction of the overex-
pressed receptor with an endogenous receptor may have an impact on the activation profile of
infected cells. Further experiments overexpressing different receptor types simultaneously in
the same cells will be needed in the future to address these questions.
Matching the immense repertoire of vomeronasal receptors to the even greater collection of
putative stimuli (the vomeronasal ligandome) and systematic analysis of ligand-receptor inter-
actions are fundamental steps towards understanding how chemical information is encoded by
the olfactory systems. Future identification of ligand-receptor pairs will define chemical coding
mechanisms during social communication, the neural circuits that are activated by specific
receptors and their ligands, and their precise roles in the control of social behaviors.
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